Order 'Fighting Fat: Break the Dieting Cycle and Get Healthy for Life!'




Short-term, restrictive diets just don’t work as long-term weight loss solutions. As soon as your diet proves unsustainable within your everyday life, you regain the weight you’ve lost while dieting, negatively impacting your biological and psychological systems as well. Sound familiar?


In Fighting Fat: Break the Dieting Cycle and Get Healthy for Life!, wellness expert and best-selling author Dr. Steven Lamm reveals why it’s more important to gain health than to simply lose pounds. With Dr. Lamm’s individualized approach to weight reduction that’s based on your unique lifestyle, biology, and risk factors, you can start to improve your overall well-being while greatly reducing your risk of countless health complications.


Groundbreaking advancements in the rapidly evolving science behind weight loss have generated many new options for people who struggle to manage their weight. From understanding the effects of prescription and over-the-counter medications to making decisions about bariatric surgery, Fighting Fat delivers Dr. Lamm’s authoritative insights and analysis of the most current and comprehensive information available.



Dr. Lamm's weekly review of relevant articles and research

There is an increasing amount of information available about the gut.  Here are a few informative articles you may find valuable.


HIV and Ecosystem

Bad Bugs Abet HIV

MedPageToday, July 12, 2013.

Increasingly, the ill effects of HIV infection -- even when controlled by highly active antiretroviral therapy (HAART) -- are being linked to chronic inflammation. Now researchers led by Joseph McCune, MD, PhD, of the University of California San Francisco, think they understand at least part of the reason.

They analyzed the gut microbiome -- all the bacteria that live in the intestinal tract -- of 34 people, including seven with untreated HIV, 18 with HIV controlled by HAART, and nine without HIV but matched for other health risks. The HIV patients, according to a report online in Science Translational Medicine, had a markedly different gut microbiome than did the uninfected participants.

Specifically, they harbored more harmful species, such as Pseudomonas, Salmonella, Escherichia coli, and Staphylococcus, that can cause inflammation. The extent of the so-called dysbiosis was correlated with tryptophan catabolism and plasma concentrations of the inflammatory cytokine interleukin-6, which are known markers of HIV progression.

One implication, they concluded, is that intestinal microbiomic engineering in HIV patients might be a new therapeutic strategy for managing disease progression.

Media Contact

Steven Lamm, MD

  • (212) 988-1146